Results 191 to 200 of about 104,287 (300)
A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis [PDF]
Haque, Reza +3 more
core +1 more source
Tuberculous Endophthalmitis With Phthisis Bulbi: A Diagnostic Delay Case Report
ABSTRACT Tuberculous endophthalmitis should be prioritized in differential diagnosis for unexplained endophthalmitis in TB‐endemic regions; early systemic evaluation, timely pars plana vitrectomy, and adjunctive corticosteroids are crucial to prevent phthisis bulbi, though evidence for some interventions remains limited.
Yanchen Chen +4 more
wiley +1 more source
Allergic conjunctivitis: Prevalence, clinical patterns, and awareness in adults: A population-based cross-sectional study in Riyadh, Saudi Arabia. [PDF]
Alkadi TA +9 more
europepmc +1 more source
ABSTRACT In dengue‐endemic regions, prolonged fever with mucocutaneous findings may represent classical Kawasaki disease (KD), dengue‐associated KD‐like inflammation, or true concomitant disease. When KD cannot be confidently excluded, timely IVIG administration may be justified to prevent coronary complications.
Saad Bin Toufeeq +5 more
wiley +1 more source
Fresh frozen plasma therapy in type I plasminogen deficiency: a case of ligneous conjunctivitis with hydrocephalus. [PDF]
AboGhayyada I +5 more
europepmc +1 more source
Parinaud's Conjunctivitis [PDF]
openaire +3 more sources
ABSTRACT Introduction Traditional fish smoking in Abuesi, Ghana, exposes workers, primarily women, to significant health risks due to prolonged smoke inhalation. This study evaluates the knowledge, attitudes, and practices (KAP) concerning safe smoking methods.
Frank Adusei‐Mensah +8 more
wiley +1 more source
Screening and surveillance for ophthalmic disorders and visual deficits in children at a tertiary care hospital in Central India. [PDF]
Gaikwad S, Saoji C, Nagrale P.
europepmc +1 more source
ABSTRACT Objective To assess whether antivirals are associated with a reduced incidence of uveitis following COVID‐19. Methods We conducted a multi‐institutional, population‐based retrospective cohort study of adults (≥ 18 years) diagnosed with COVID‐19 between 2022 and 2024. Patients who received antiviral agents (Paxlovid, Molnupiravir, or Remdesivir)
Hou‐Ting Kuo +14 more
wiley +1 more source

